Innovative
Longevity
Solutions
European Advanced Specialization Course
LONGEVITY MEDICINE
Foundations for professional practice.
The first training program, specifically designed for medical professionals who wish to integrate the most advanced knowledge of biology and clinical practice to promote healthy longevity into their daily practice.
Course organized by Fondazione SoLongevity
In collaboration with ECM Office, University of Pavia.
30+30 ECM
- High-profile Scientific Committee
- 30 Professors and industry experts
- 76 total hours asynchronous teaching
- 1 week optional internship (40 hours)
- Presentations from the Milan Longevity Summit included
- Course in English
Two independent and coordinated modules:
MODULE 1 – Longevity Diagnostics
MODULE 2 – Longevity Therapeutics
Presentation Longevity Medicine Course [Highlights]
Age360° Program™
Age360° Program™ is a program based on the precision medicine method, designed to promote physiological rejuvenation and counteract the conditions underlying the onset of chronic non-communicable diseases.
Milan Longevity Summit
Living Longevity.
The Milan Longevity Summit day, “Living Longevity: from the frontiers of Science to everyday life”, organized…
The Foundation’s Manifesto
Fondazione SoLongevity aims to make a specific contribution to the translational dimension of Longevity Science in healthcare, by promoting information, education and empowerment for both citizens and healthcare professionals.
More specifically, the Foundation has set itself the following priority objectives:
- Information and training on the biomedical technologies involved in primary and secondary prevention and in Longevity Medicine. Programs for physicians and all healthcare practitioners, delivered as informational and educational events (ECM).
- Programs to inform citizens on topics related to prevention and healthy aging, focused on lifestyle and health-monitoring technologies.
- Promotion, with the public bodies governing the Italian National Health Service (SSN), of technological innovations in preventive medicine that are suitable for adoption by the SSN. Organization and co-funding of clinical studies to validate the selected technologies.
- Support for scientific research into the development of intelligent systems for managing and interpreting data generated by: (1) “omics” risk-assessment technologies; (2) wearables and other health-monitoring devices.